Literature DB >> 18679759

A "biomarker biopsy" for the diagnosis of NASH: promises from CK-18 fragments.

Yusuf Yilmaz, Engin Ulukaya, Enver Dolar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18679759     DOI： 10.1007/s11695-008-9639-z

Source DB:  PubMed          Journal:  Obes Surg        ISSN： 0960-8923            Impact factor:   4.129


× No keyword cloud information.
  5 in total

1.  In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease.

Authors:  Anna Wieckowska; Nizar N Zein; Lisa M Yerian; A Rocio Lopez; Arthur J McCullough; Ariel E Feldstein
Journal:  Hepatology       Date:  2006-07       Impact factor: 17.425

2.  Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis.

Authors:  Yusuf Yilmaz; Enver Dolar; Engin Ulukaya; Semra Akgoz; Murat Keskin; Murat Kiyici; Sibel Aker; Arzu Yilmaztepe; Selim Gurel; Macit Gulten; Selim-Giray Nak
Journal:  World J Gastroenterol       Date:  2007-02-14       Impact factor: 5.742

3.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

4.  A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH).

Authors:  Zobair M Younossi; Mohammed Jarrar; Clare Nugent; Manpreet Randhawa; Mariam Afendy; Maria Stepanova; Nila Rafiq; Zachary Goodman; Vikas Chandhoke; Ancha Baranova
Journal:  Obes Surg       Date:  2008-05-24       Impact factor: 4.129

5.  Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease.

Authors:  Thierry Poynard; Vlad Ratziu; Frederic Charlotte; Djamila Messous; Mona Munteanu; Françoise Imbert-Bismut; Julien Massard; Luninita Bonyhay; Mohamed Tahiri; Dominique Thabut; Jean François Cadranel; Brigitte Le Bail; Victor de Ledinghen
Journal:  BMC Gastroenterol       Date:  2006-11-10       Impact factor: 3.067
  5 in total
  5 in total

1.  Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis.

Authors:  Zobair M Younossi; Rohit Loomba; Quentin M Anstee; Mary E Rinella; Elisabetta Bugianesi; Giulio Marchesini; Brent A Neuschwander-Tetri; Lawrence Serfaty; Francesco Negro; Stephen H Caldwell; Vlad Ratziu; Kathleen E Corey; Scott L Friedman; Manal F Abdelmalek; Stephen A Harrison; Arun J Sanyal; Joel E Lavine; Philippe Mathurin; Michael R Charlton; Zachary D Goodman; Naga P Chalasani; Kris V Kowdley; Jacob George; Keith Lindor
Journal:  Hepatology       Date:  2018-07       Impact factor: 17.425

Review 2.  Clinical approaches to non-alcoholic fatty liver disease.

Authors:  Katherine J P Schwenger; Johane P Allard
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

Review 3.  Cytokeratin-18 fragments and biomarkers of the metabolic syndrome in nonalcoholic steatohepatitis.

Authors:  Yusuf Yilmaz; Alla Eldeen Kedrah; Osman Ozdogan
Journal:  World J Gastroenterol       Date:  2009-09-21       Impact factor: 5.742

Review 4.  Molecular pathways in non-alcoholic fatty liver disease.

Authors:  Alba Berlanga; Esther Guiu-Jurado; José Antonio Porras; Teresa Auguet
Journal:  Clin Exp Gastroenterol       Date:  2014-07-05

Review 5.  Diagnostic Value of CK-18, FGF-21, and Related Biomarker Panel in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.

Authors:  Lei He; Linfeng Deng; Quan Zhang; Jianli Guo; Jinan Zhou; Wenjian Song; Fahu Yuan
Journal:  Biomed Res Int       Date:  2017-02-23       Impact factor: 3.411
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.